European ADRs Move Lower

American depositary receipts of European stocks were trading 0.43% lower at 1,048.72 on the BNY Mellon Europe Select ADR Index on Thursday.

In continental Europe, the gainers were led by medical device maker Edap (EDAP), which surged 19.3%, followed by network infrastructure provider Nokia (NOK), brewing company AB InBev (BUD) and biotech firm Zealand Pharma (ZEAL), which climbed 7.9%, 6.8%, and 2.5% respectively.

The decliners in continental Europe were led by biotech company Forward Pharma (FWP) and pharmaceutical firm Oasmia Pharmaceutical (OASM), which fell 5.8% and 5% respectively. They were followed by ABB (ABB) and semiconductor company STMicroelectronics (STM), which were off 2.8% and 2.3%.

In the UK and Ireland, the gainers were led by pharmaceutical company AstraZeneca (AZN) and biotech firm Autolus Therapeutics (AUTL), which rose 7.2% and 3.2% respectively. They were followed by biopharmaceutical company NuCana (NCNA) and Trinity Biotech (TRIB) were up 3.2% and 1.9%.

The decliners in the UK and Ireland were led by biopharmaceutical company Adaptimmune Therapeutics (ADAP) and analytics and information provider RELX PLC (RELX), which fell 3.3% each. They were followed by alcoholic beverage company Diageo (DEO) and insurance firm Prudential (PUK), which lost 2.3% each.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *